Status:
ACTIVE_NOT_RECRUITING
Quality of Life After Hysterectomy (AdenoQOL)
Lead Sponsor:
Oslo University Hospital
Conditions:
Adenomyosis
Quality of Life
Eligibility:
FEMALE
18-52 years
Brief Summary
Adenomyosis is a disease where ectopic endometrial-like glands affect the muscular wall of the uterus. About 70% of women affected by adenomyosis suffer from dysmenorrhea and menorrhagia. A levonorges...
Eligibility Criteria
Inclusion
- Premenopausal status defined by having had menstruation within the last 12 months, or age \< 50 years if amenorrhea due to hormonal treatment
- Hysterectomy planned due to a benign condition
- Able to communicate in Norwegian or English
- Electronic consent given
Exclusion
- Age \< 18 years, postmenopausal status or no menstrual bleeding for the last 12 months
- Hysterectomy as part of female-to-male transition
- Pelvic organ prolapse as an indication for hysterectomy
- Gynecological cancer suspected at the time of inclusion
- Not able to communicate in Norwegian or English
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT04791033
Start Date
March 18 2021
End Date
December 1 2030
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marianne Omtvedt
Oslo, Norway